Yazar "Hooshiar, Mohammad Hosseini" seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • [ X ]
    Öğe
    Artificial intelligence-driven epigenetic CRISPR therapeutics: a structured multi-domain meta-analysis of therapeutic efficacy, off-target prediction, and gRNA optimization
    (Springer Heidelberg, 2025) Basarali, Mustafa Kemal; Daemi, Amin; Tahiraga, Ruhiyya Guliyeva; Ozbolat, Guluzar; Hooshiar, Mohammad Hosseini; Shirazi, Malihe Sagheb Ray; Dogus, Yusuf
    CRISPR-based epigenetic editing enables reversible regulation of gene expression without permanent DNA modification. The integration of artificial intelligence (AI) enhances guide RNA (gRNA) design, off-target prediction, and delivery optimization. We conducted a systematic review and meta-analysis (2015-2025) in accordance with PRISMA 2020 guidelines to evaluate the impact of AI on the precision, safety, and therapeutic efficacy of epigenetic CRISPR tools. From 540 screened records, 58 studies met inclusion criteria, of which 41 provided extractable quantitative data for meta-analysis and 17 contributed to qualitative synthesis. Random-effects models, subgroup analyses, and bias assessments were applied. Pooled analyses demonstrated strong positive effects across three domains: therapeutic efficacy (SMD = 1.67), gRNA optimization (SMD = 1.44), and off-target prediction (AUC = 0.79). Publication bias was minimal, and subgroup analyses indicated the strongest impact in therapeutic applications. Deep learning models were consistently associated with higher effect sizes. Qualitative synthesis revealed trends in interpretable AI, omics integration, and delivery innovations, underscoring AI's role in safer and more precise CRISPR editing. Overall, AI significantly improves the precision and therapeutic performance of CRISPR-based epigenetic tools, with the strongest effects observed in therapeutic efficacy, supporting their potential for personalized gene editing.
  • [ X ]
    Öğe
    Revolutionizing personalized medicine using artificial intelligence: a meta-analysis of predictive diagnostics and their impacts on drug development
    (Springer-Verlag Italia Srl, 2025) Daemi, Amin; Kalami, Sahar; Tahiraga, Ruhiyya Guliyeva; Ghanbarpour, Omid; Barghani, Mohammad Reza Rahimi; Hooshiar, Mohammad Hosseini; Ozbolat, Guluzar
    Artificial intelligence (AI) is transforming the landscape of laboratory medicine by enhancing diagnostic accuracy and enabling more personalized care. Given its growing use in clinical settings, evaluating the performance of AI models in diagnostic tasks is essential to inform evidence-based implementation strategies. This meta-analysis systematically assessed the diagnostic effectiveness of AI-based models. A comprehensive literature search was conducted in PubMed, Scopus, Web of Science, and IEEE Xplore using predefined keywords related to AI and diagnostic accuracy. From 430 retrieved studies, 17 met the inclusion criteria. Data extracted included study design, AI model type, input modality, and performance metrics such as sensitivity, specificity, and area under the curve (AUC). Random-effects meta-analysis and subgroup analyses were performed to investigate heterogeneity and model-specific trends. The pooled analysis yielded a high combined AUC of 0.9025, indicating strong diagnostic capability of AI models. However, substantial heterogeneity was detected (I2 = 91.01%), attributed to differences in model architecture, diagnostic domains, and data quality. Subgroup analyses showed that convolutional neural networks and random forest models achieved higher AUC values, while domains like endocrinology demonstrated greater performance variability. Funnel plot inspection and sensitivity analysis indicated the presence of publication bias. AI shows strong potential to enhance diagnostic accuracy in personalized laboratory medicine. Nonetheless, methodological heterogeneity and publication bias remain significant challenges. Future research should prioritize standardized evaluation frameworks, transparency, and the development of explainable AI systems to ensure responsible clinical integration.